Logotype for Dimed S.A. Distribuidora de Medicamentos

Dimed (PNVL3) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Dimed S.A. Distribuidora de Medicamentos

Q3 2024 earnings summary

30 Aug, 2026

Executive summary

  • Achieved strong recovery in 3Q24 after flood disruptions in 2Q24, with retail revenue up 17.0% year-over-year and operations normalized, driven by same-store sales growth of 14.1% and mature stores up 11.4%.

  • Digital channels reached a record 21.2% of retail sales, with app sales up 35.3% year-over-year and rapid delivery supporting customer loyalty.

  • Adjusted EBITDA grew 26.8% to R$71.8 million (5.4% margin), and net income rose 37.1% to R$37.3 million (2.8% margin).

  • Market share in the South region increased for the 18th consecutive quarter, reaching 12.5%, with gains in all southern states.

  • Expansion resumed with 14–15 new stores in Q3, reaching 612 stores, and continued investment in technology and AI.

Financial highlights

  • Retail gross revenue reached R$1.289 billion (+17.0% YoY), with consolidated gross margin at 29.4% (+1.2 p.p.), and retail gross margin at 29.9%.

  • Same-store sales grew 14.1% and mature store sales 11.4%, both well above inflation (4.4%).

  • Retail EBITDA margin increased to 11.7% year-over-year.

  • Free cash flow was -R$72.5 million, mainly due to inventory investments and store openings.

  • Operating expenses grew below retail sales: selling expenses +11.5%, administrative expenses +8.4%.

Outlook and guidance

  • Guidance reaffirmed to open 60 new stores in 2024, with continued margin expansion, efficiency gains, and leverage reduction.

  • Expects normalization of Panvel-branded product supply and strong sales in the second half.

  • No significant margin risk anticipated from upcoming tax changes; proactive measures in place.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more